University of Hyderabad researchers have secured an Indian patent for a lactoferrin nanoparticle-based formulation combining curcumin with antiretroviral drugs. Laboratory and animal studies showed controlled drug release, sustained antiviral activity, lower systemic absorption and reduced tissue damage following vaginal administration, researchers said
